The turning points in the ITB were pretty clearly defined, but that is not always the case. Regeneron Pharmaceuticals ( REGN ) was another leader in 2012 as it was up 208.62%. The long-term chart shows that it became a market leader initially in February 2011, line 1, as the RS line had moved above resistance that went back several years.